Viability and telomere length analysis of Mesenchymal Stromal Cells

Main Article Content

Patana Teng-umnuay
Panurut Yanudom
Jettana Rongdet

Abstract

Mesenchymal stromal cells (MSCs) have provided various potential clinical applications, particularly due to their immunomodulation and tissue repair abilities. To develop cellular therapy products based on human MSCs, some basic requirements should be implemented. These include the choice of MSCs source, cultivation media and methods, and sterility tests. In this study, cell viability and telomere length analysis have been applied to ensure optimal and consistent therapeutic results of MSCs therapy.

Article Details

How to Cite
Teng-umnuay, P., Yanudom, P., & Rongdet, J. (2017). Viability and telomere length analysis of Mesenchymal Stromal Cells. Interdisciplinary Research Review, 12(3), 50–53. https://doi.org/10.14456/jtir.2017.20
Section
Research Articles
Author Biography

Patana Teng-umnuay, Dhurakij Pundit University

  • Faculty, Master Program of Anti-aging and Regenerative Medicine, Dhurakij Pundit University.
  • Vice president, A4M Thailand
  • Member, The National Cell Therapy and Regenerative Medicine Committee
  • Advisor, Association of Cell Therapy Thailand (ACT)
  • Advisor, Chelation Medical Association, Thailand (CMAT)
    • Member, The Royal College of Physicians of Thailand
    • Member, The Thai Society of Nephrology
    • Member, The International Society of Nephrology
    • Member, The International Society for Cellular Therapy (ISCT)